Skip to content
Sexuality – Lifestyle
Author:
Amplia Therapeutics Limited
Amplia Announces Changes to Board’s Leadership Roles
July 6, 2026
Following Significant Advances at ASCO, Amplia Therapeutics Provides Letter to Shareholders Highlighting the Potential Opportunities for Combination with KRAS Inhibition in Pancreatic Cancer
June 22, 2026